Anticancer-agent-84-DataSheet-生命科學(xué)試劑-MCE_第1頁
Anticancer-agent-84-DataSheet-生命科學(xué)試劑-MCE_第2頁
Anticancer-agent-84-DataSheet-生命科學(xué)試劑-MCE_第3頁
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)

文檔簡介

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemEAnticanceragent84Cat.No.:HY-151471CASNo.:2714510-72-0分?式:C??H??N?O?分?量:994.18作?靶點(diǎn):c-Myc作?通路:Apoptosis儲存?式:PleasestoretheproductundertherecommendedconditionsintheCertificateofAnalysis.BIOLOGICALACTIVITY?物活性Anticanceragent84抗癌劑。Anticanceragent84通過穩(wěn)定G-四鏈體(G4)結(jié)構(gòu)來抑制c-MYC的轉(zhuǎn)錄。Anticanceragent84可?于癌癥研究。IC50&TargetIC50:5.0μM(HepG2);3.9μM(MDA-MB-231);>100μM(HBL-100)[1]體外研究Anticanceragent84hascytotoxicityincancercells(HepG2,MDA-MB-231)andnormalcells(HBL-100)withIC50valuesof5.0μM,3.9μMand>100μM,respectively[1].Anticanceragent84displaysgoodc-MYCG4bindingandstabilizationabilities[1].Anticanceragent84blocksc-MYCtranscriptionbytargetingthepromoterG4,leadingtoc-MYC-dependentcancercelldeathintriple-negativebreastcancercellMDA-MB-23[1].Anticanceragent84(2μM)significantlydisruptsthebindingofthethreeproteins(NM23-H2,BLMandDHX36)toc-MYCG4withIC50valuesof0.16μM,2.3μMand7.0μM,respectively[1].Anticanceragent84(0-5μM)impactsc-MYC-relatedeventsinTNBC,includingproliferation,invasion,cellcycle,andapoptosis[1].WesternBlotAnalysis[1]CellLine:MDA-MB-231cellsConcentration:1.25,2.5,5μMIncubationTime:48hResult:DecreasedthemRNAlevelsofc-MYC.1/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemECellCycleAnalysis[1]CellLine:MDA-MB-231cellsConcentration:1.25,2.5,5μMIncubationTime:24hResult:CouldarrestMDA-MB-231cellsattheSubG0phase.ApoptosisAnalysis[1]CellLine:MDA-MB-231cellsConcentration:1.25,2.5,5μMIncubationTime:24hResult:InducedearlyapoptosisandnecrosisinMDA-MB-231cells.RT-PCR[1]CellLine:MDA-MB-231cellsConcentration:1.25,2.5μMIncubationTime:24hResult:Exhibitedrelativelyweakeffectsonothergenesandsuppressedc-MYCtranscriptionbytargetingc-MYCG4.CellCytotoxicityAssay[1]CellLine:MDA-MB-231cellsConcentration:IncubationTime:48hResult:Displayedgoodcytotoxicityagainstvariouscancercells,includingMDA-MB-231,MCF-7,HepG2,andSiHaanddisplayedlesscytotoxicityagainstnormalHBL-100andNCM460cells.CellProliferationAssay[1]CellLine:MDA-MB-231cellsConcentration:1.25,2.5,5μMIncubationTime:10days2/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemEResult:Exhibitsgoodantiproliferativeactivity.CellInvasionAssay[1]CellLine:MDA-MB-231cellsConcentration:1.25,2.5,5μMIncubationTime:24hResult:ObviouslydecreasedtheinvasionwithanIC50valueof1.7μM.體內(nèi)研究Anticanceragent84(i.p.;2.5mg/kg;daily;for24days)significantlyinhibitstumorgrowthintheMDAMB-231mousexenograftmodelaccompaniedbyc-MYCdownregulation[1].AnimalModel:BALB/C-nu/numice(female,five-week-aged,10?12g)[1]Dosage:2.5mg/kgAdministration:intraperitoneally,daily,for24daysResult:Exhibitedpotentantitumoractivityandcouldactasac-MYCrepressorinvivo.REFERENCES[1].Mao-LinLi,etal.Design,Synthesis,andEvaluationofNewSugar-SubstitutedImidazoleDerivativesasSelectivec-MYCTranscriptionRepressorsTargetingthePromoterG-Quadruplex.JMedChem.2022Sep19.McePdfHeightCaution:Producthasnotbeenfullyv

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論